Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis clinical trial (NCT00002169). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Viracept compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis clinical trial (NCT00002169). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from Viracept?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis clinical trial (NCT00002169). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis clinical trial (NCT00002169). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis clinical trial (NCT00002169). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will the treatment last?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis clinical trial (NCT00002169). Contact the study team or your healthcare provider for specific answers.

What this study is about